Antoinette Chevreau

addmedica

addmedica is a fast growing company focused on developing and marketing medical products for: • rare diseases • unmet medical needs in developed and emerging countries • serious conditions addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. addmedica's strategic areas of interest comprise: • wound healing, tissue growth and cell regeneration • organ transplant, tissue replacement • genetic diseases, drug or substitute therapy, cell or gene therapy addmedica, complying with its pharmaceutical status, is proud to offer a range of products in the fields of • lung transplantation, • wound healing and deep burn care. • sickle cell disease (European Orphan Medicinal Product) addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand. As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.